Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
About Index
Index
By TNW
Log in
Register
Corindus
3950
Corindus
Industry
Manufacturing
Robotics
Software
Corindus Vascular Robotics is developing the new standard of care for angioplasty procedures through the CorPath Vascular Robotic Program.
Suggest edits
Founded
2001
Raised
$96.6M
Follow us
Companies in the same industry
Twitter
极客公园
Numob
GNARBOX
0glass
QKM Technology
OpenDrives
Paracosm
BluHaptics
FiveAI
Alexa global traffic share
Twitter followers
Overview
Funding
3
Investments
1
Add info
Acquired by
1
08 Aug 2019
Siemens
$1,100,000,000
Latest funding
Show all
$25,000,000
Post-IPO equity - 2018
BioStar Ventures
Hudson Executive Capital
$45,000,000
Private equity - 2017
HealthCor Partners
Boston Scientific
BioStar Ventures
+3
Location
United States
Headquarters
Explore United States
$1,100,000,000
Reuters Top News
Germany's Siemens Healthineers buys U.S. firm Corindus for $1.1...
Robotics
The Robot Report
Corindus completes first-in-human telerobotic coronary intervention
Robotics
The Robot Report
Corindus CorPath GRX surgical robot receives clearance in Japan
Robotics
Health
Intelligent machines
Asia
$25,000,000
Post-IPO equity
The Robot Report
Corindus Raises $25M for CorPath GRX Surgical Robot
Robotics
Funding
Intelligent machines
Stock markets
The Robot Report
Corindus joins with Mayo Clinic in study of tele-robotic stenting
Robotics
Health
Intelligent machines
The Robot Report
Corindus touts 1st Corpath GRX system installation outside the US
Robotics
Intelligent machines
Health
The Robot Report
Corindus Vascular Robotics to test-drive HeartFlow's 3D cardiac imaging tech
Robotics
Health
Intelligent machines
The Robot Report
Corindus opens first international training center for CorPath GRX System
Robotics
Intelligent machines
Health
Asia
The Robot Report
Corindus launches post-approval study for CorPath GRX coronary system
Robotics
Health
$45,000,000
Private equity
PE HUB
Corindus Vascular Robotics closes $45 mln private placement
Funding
